| 2026-08-06 | 10-Q | 10.2 | Credit Agreement, dated as of August 3, 2026, by and between the Company and PD Joint Holdings, LLC Series 2016-B. |
|---|
| 2026-06-09 | 8-K | 10.1 | Amended and Restated 2018 Equity Incentive Plan. |
|---|
| 2026-03-11 | 10-K | 10.31 | Employment Agreement, by and between the Registrant and Noah Rosenberg, dated as of March 19, 2025. |
|---|
| 2025-11-24 | 8-K | 10.3 | Form of Registration Rights Agreement, dated November 23, 2025, by and among Verrica Pharmaceuticals, Inc. and the Purchasers. |
|---|
| 2025-11-24 | 8-K | 10.2 | Form of Securities Purchase Agreement with other accredited investors, dated November 23, 2025 |
|---|
| 2025-11-24 | 8-K | 10.1 | Form of Securities Purchase Agreement with institutional investors, dated November 23, 2025 |
|---|
| 2025-08-12 | 10-Q | 10.2 | Second Amendment to Collaboration and License Agreement, dated as of June 27, 2025, by and between the Company and Torii Pharmaceuticals Co., Ltd. |
|---|
| 2025-08-12 | 10-Q | 10.1 | Sixth Amendment and Waiver to Credit Agreement dated as of June 10, 2025, by and between the Company and OrbiMed Royalty & Credit Opportunities IV, LP. |
|---|
| 2025-05-13 | 10-Q | 10.2 | Waiver, dated February 18, 2025, by and between the Company and Orbimed Royalty & Credit Opportunities IV, LP. |
|---|
| 2025-04-25 | 8-K | 10.1 | Release Agreement, dated April 24, 2025, by and between the Company and Christopher G. Hayes. |
|---|
| 2024-12-09 | 8-K | 10.2 | Amendment to 2024 Inducement Plan |
|---|
| 2024-12-09 | 8-K | 10.1 | Offer Letter, dated December 5, 2024, by and between the Company and David Zawitz |
|---|
| 2024-11-05 | 10-Q | 10.2 | Release and Consulting Agreement, dated as of August 30, 2024, by and between the Registrant and Joseph Bonaccorso |
|---|
| 2024-11-05 | 10-Q | 10.1 | Fifth Amendment to Credit Agreement, dated as of August 2, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP. |
|---|
| 2024-11-04 | 8-K | 10.6 | Form of Stock Option Grant Notice and Stock Option Agreement under 2024 Inducement Plan |
|---|
| 2024-11-04 | 8-K | 10.5 | Form of Restricted Stock Unit Award Grant Notice and Award Agreement under 2024 Inducement Plan |
|---|
| 2024-11-04 | 8-K | 10.4 | Verrica Pharmaceuticals, Inc. 2024 Inducement Plan |
|---|
| 2024-11-04 | 8-K | 10.3 | Professional Services Agreement, dated November 4, 2024, by and between the Company and John J. Kirby |
|---|
| 2024-11-04 | 8-K | 10.2 | Offer Letter, dated November 4, 2024, by and between the Company and Jayson Rieger |
|---|
| 2024-11-04 | 8-K | 10.1 | Release Agreement, dated November 4, 2024, by and between the Company and Ted White |
|---|
| 2024-08-14 | 10-Q | 10.4 | First Amendment to Collaboration and License Agreement, dated as of May 14, 2024, by and between the Registrant and Torii Pharmaceuticals Co., Ltd. |
|---|
| 2024-08-14 | 10-Q | 10.3 | Fifth Amendment to Credit Agreement, dated as of August 2, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP. |
|---|
| 2024-08-14 | 10-Q | 10.2 | Fourth Amendment to Credit Agreement, dated as of June 26, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP. |
|---|
| 2024-08-14 | 10-Q | 10.1 | Third Amendment to Credit Agreement, dated as of May 6, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP. |
|---|
| 2024-02-29 | 10-K | 10.28 | Second Amendment to Credit Agreement, dated as of January 31, 2024, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP. |
|---|
| 2024-02-29 | 10-K | 10.27 | First Amendment to Credit Agreement, dated as of December 20, 2023, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP. |
|---|
| 2024-02-29 | 10-K | 10.21 | Second Amended and Restated Non-Employee Director Compensation Policy, adopted by the Board as of February 27, 2024 |
|---|
| 2023-11-09 | 10-Q | 10.3 | Warrant Certificate, dated as of July 26, 2023, by and between Verrica Pharmaceuticals, Inc. and Orbimed Royalty & Credit Opportunities IV, LP |
|---|
| 2023-11-09 | 10-Q | 10.2 | Pledge and Security Agreement, dated as of July 26, 2023, by and between Verrica Pharmaceuticals, Inc. and Orbimed Royalty & Credit Opportunities IV, LP |
|---|
| 2023-11-09 | 10-Q | 10.1 | Credit Agreement, dated as of July 26, 2023, by and between Verrica Pharmaceuticals, Inc. and Orbimed Royalty & Credit Opportunities IV, LP |
|---|
| 2022-03-02 | 10-K | 10.28 | Waiver and Second Amendment to Loan and Security Agreement, dated as of March 1, 2022. |
|---|
| 2022-03-02 | 10-K | 10.27 | Amended and Restated Non-Employee Director Compensation Policy, adopted by the Board as of February 24, 2022 |
|---|
| 2022-03-02 | 10-K | 10.26 | Waiver and Second Amendment to Mezzanine Loan and Security Agreement, dated as of March 1, 2022 |
|---|
| 2022-03-02 | 10-K | 10.24 | .Employment Agreement, by and between the Registrant and Christopher Hayes, dated as of February 27, 2020. |
|---|
| 2022-03-02 | 10-K | 10.23 | Employment Agreement by and between the Registrant and Gary Goldenberg, dated as of August 1, 2020. |
|---|
| 2021-11-12 | 10-Q | 10.1 | Employment Agreement, by and between Verrica Pharmaceuticals Inc. and Terry Kohler, dated July 16, 2021 (filed herewith). |
|---|
| 2021-08-10 | 10-Q | 10.1 | Amended and Restated Non-Employee Director Compensation Policy (filed herewith). |
|---|
| 2021-05-07 | 10-Q | 10.1 | Collaboration and License Agreement, by and between the Company and Torii Pharmaceutical Co., Ltd., dated March 17, 2021 (filed herewith). |
|---|
| 2021-03-17 | 10-K | 10.22 | First Amendment to Mezzanine Loan and Security Agreement, by and among the Company, Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, L.P., dated as of October 26, 2020. |
|---|
| 2021-03-17 | 10-K | 10.21 | First Amendment to Loan and Security Agreement, by and between the Company and Silicon Valley Bank, dated as of October 26, 2020. |
|---|
| 2020-11-09 | 10-Q | 10.1 | Exclusive License Agreement, by and between the Registrant and Lytix Biopharma AS, dated as of August 7, 2020 |
|---|
| 2020-08-05 | 10-Q | 10.1 | Second Amendment to Lease Agreement, by and between the Registrant and 44 West Gay LLC, dated as of April 27, 2020 (filed herewith). |
|---|
| 2020-05-07 | 10-Q | 10.5 | First Amendment to Lease Agreement, by and between the Registrant and 44 West Gay LLC, dated as of March 12, 2020. |
|---|
| 2020-05-07 | 10-Q | 10.2 | Mezzanine Loan and Security Agreement, by and among the Company, Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, L.P., dated as of March 10, 2020. |
|---|
| 2020-05-07 | 10-Q | 10.1 | Loan and Security Agreement, by and between the Company and Silicon Valley Bank, dated as of March 10, 2020. |
|---|
| 2020-03-13 | 10-K | 10.20 | Amended and Restated Employment Agreement, by and between the Registrant and Patrick Burnett, dated as of January 10, 2020. |
|---|
| 2020-03-13 | 10-K | 10.19 | Amended and Restated Employment Agreement, by and between the Registrant and Joe Bonaccorso, dated as of January 10, 2020. |
|---|
| 2020-03-13 | 10-K | 10.18 | Amended and Restated Employment Agreement, by and between the Registrant and Ted White, dated as of January 10, 2020. |
|---|
| 2019-11-06 | 10-Q | 10.2 | Third Amendment to Services Agreement, by and between the Company and PBM Capital Group, LLC, dated as of October 1, 2019. |
|---|
| 2019-10-10 | 8-K | 10.1 | Offer Letter, by and between the Company and Brian Davis, dated as of October 4, 2019. |
|---|
| 2019-07-01 | 8-K | 10.1 | Lease Agreement dated July 1, 2019 between the Company and 44 West Gay LLC |
|---|
| 2019-03-07 | 10-K | 10.19 | Second Amendment to Services Agreement, by and between the Registrant and PBM Capital Group, LLC, dated as of January 1, 2019. |
|---|
| 2018-11-07 | 10-Q | 10.1 | Supply Agreement, by and between the Company and Funing County Development Brucea Javanica Professional Cooperatives, dated as of July 16, 2018. |
|---|